Predictive Oncology ROA 2010-2024 | POAI
Current and historical return on assets (ROA) values for Predictive Oncology (POAI) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Predictive Oncology ROA - Return on Assets Historical Data |
Date |
TTM Net Income |
Total Assets |
Return on Assets |
2024-09-30 |
$-0.01B |
$0.01B |
-120.93% |
2024-06-30 |
$-0.01B |
$0.01B |
-96.30% |
2024-03-31 |
$-0.01B |
$0.01B |
-87.50% |
2023-12-31 |
$-0.01B |
$0.01B |
-66.67% |
2023-09-30 |
$-0.02B |
$0.02B |
-80.00% |
2023-06-30 |
$-0.02B |
$0.02B |
-72.38% |
2023-03-31 |
$-0.03B |
$0.03B |
-83.33% |
2022-12-31 |
$-0.03B |
$0.03B |
-74.07% |
2022-09-30 |
$-0.03B |
$0.03B |
-65.36% |
2022-06-30 |
$-0.03B |
$0.04B |
-60.82% |
2022-03-31 |
$-0.02B |
$0.04B |
-39.58% |
2021-12-31 |
$-0.02B |
$0.04B |
-41.67% |
2021-09-30 |
$-0.02B |
$0.05B |
-57.14% |
2021-06-30 |
$-0.03B |
$0.06B |
-74.07% |
2021-03-31 |
$-0.03B |
$0.04B |
-99.05% |
2020-12-31 |
$-0.03B |
$0.01B |
-120.00% |
2020-09-30 |
$-0.03B |
$0.03B |
-121.21% |
2020-06-30 |
$-0.03B |
$0.03B |
-101.89% |
2020-03-31 |
$-0.02B |
$0.03B |
-79.28% |
2019-12-31 |
$-0.02B |
$0.02B |
-87.91% |
2019-09-30 |
$-0.01B |
$0.03B |
-49.32% |
2019-06-30 |
$-0.01B |
$0.03B |
-69.57% |
2019-03-31 |
$-0.01B |
$0.01B |
-244.44% |
2018-12-31 |
$-0.01B |
$0.00B |
-210.53% |
2018-09-30 |
$-0.01B |
$0.01B |
-168.42% |
2018-06-30 |
$-0.01B |
$0.00B |
-141.18% |
2018-03-31 |
$-0.01B |
$0.01B |
-155.56% |
2017-12-31 |
$-0.01B |
$0.00B |
-141.18% |
2017-09-30 |
$-0.01B |
$0.00B |
-150.00% |
2017-06-30 |
$-0.01B |
$0.01B |
-160.00% |
2017-03-31 |
$-0.01B |
$0.01B |
-184.62% |
2016-12-31 |
$-0.01B |
$0.00B |
-233.33% |
2016-09-30 |
$-0.01B |
$0.00B |
-213.33% |
2016-06-30 |
$-0.01B |
$0.00B |
-152.38% |
2016-03-31 |
$-0.01B |
$0.00B |
-126.32% |
2015-12-31 |
$-0.00B |
$0.01B |
-100.00% |
2015-09-30 |
$-0.00B |
$0.01B |
-145.45% |
2015-06-30 |
$-0.00B |
$0.00B |
-400.00% |
2015-03-31 |
$-0.01B |
$0.00B |
-500.00% |
2014-12-31 |
$-0.01B |
$0.00B |
-700.00% |
2014-09-30 |
$-0.01B |
$0.00B |
-700.00% |
2014-06-30 |
$-0.01B |
$0.00B |
-1000.00% |
2014-03-31 |
$-0.01B |
$0.00B |
-1200.00% |
2013-12-31 |
$-0.01B |
$0.00B |
-1200.00% |
2013-09-30 |
$-0.01B |
$0.00B |
-1800.00% |
2013-06-30 |
$-0.01B |
$0.00B |
-3200.00% |
2013-03-31 |
$-0.01B |
$0.00B |
-3600.00% |
2012-12-31 |
$-0.01B |
$0.00B |
inf% |
2012-09-30 |
$-0.01B |
$0.00B |
inf% |
2012-06-30 |
$-0.01B |
$0.00B |
inf% |
2012-03-31 |
$-0.01B |
$0.00B |
inf% |
2011-12-31 |
$-0.00B |
$0.00B |
inf% |
2011-09-30 |
$-0.00B |
$0.00B |
inf% |
2011-06-30 |
$0.00B |
$0.00B |
nan% |
2011-03-31 |
$0.00B |
$0.00B |
nan% |
2010-12-31 |
$-0.00B |
$0.00B |
inf% |
2010-09-30 |
$-0.00B |
$0.00B |
inf% |
2010-06-30 |
$-0.00B |
$0.00B |
inf% |
2010-03-31 |
$-0.00B |
$0.00B |
inf% |
2009-12-31 |
$-0.00B |
$0.00B |
inf% |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
Medical Information Systems |
$0.004B |
$0.002B |
Predictive Oncology Inc. is focused on applying artificial intelligence to personalized medicine and drug discovery. Its operating business unit consists of Helomics, TumorGenesis and Skyline Medical. Predictive Oncology Inc., formerly known as Precision Therapeutics Inc., is based in MINNEAPOLIS.
|